Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 19.66
(-0.61%)
CNY 19.66
(-0.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 95.84 Million CNY | 113.11% |
| 2022 | 98.74 Million CNY | 5.35% |
| 2021 | 93.72 Million CNY | 43.4% |
| 2020 | 65.35 Million CNY | 9.32% |
| 2019 | 59.78 Million CNY | 25.98% |
| 2018 | 47.45 Million CNY | 13.11% |
| 2017 | 41.95 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 25.71 Million CNY | 7.51% |
| 2024 Q3 | 28.31 Million CNY | -0.34% |
| 2024 Q1 | 23.91 Million CNY | -62.74% |
| 2023 Q3 | 24.68 Million CNY | -12.59% |
| 2023 FY | 210.43 Million CNY | 113.11% |
| 2023 Q4 | 64.19 Million CNY | 160.0% |
| 2023 Q2 | 28.24 Million CNY | 17.07% |
| 2023 Q1 | 24.12 Million CNY | -19.82% |
| 2022 Q3 | 24.47 Million CNY | 14.12% |
| 2022 Q2 | 21.45 Million CNY | -5.59% |
| 2022 Q1 | 22.72 Million CNY | -30.09% |
| 2022 FY | 98.74 Million CNY | 5.35% |
| 2022 Q4 | 30.09 Million CNY | 22.94% |
| 2021 Q1 | 15.48 Million CNY | -21.75% |
| 2021 Q4 | 32.5 Million CNY | 42.29% |
| 2021 FY | 93.72 Million CNY | 43.4% |
| 2021 Q3 | 22.84 Million CNY | -0.25% |
| 2021 Q2 | 22.89 Million CNY | 47.85% |
| 2020 Q3 | 18.38 Million CNY | 235.19% |
| 2020 Q1 | -12.41 Million CNY | -166.48% |
| 2020 Q2 | -13.59 Million CNY | -9.49% |
| 2020 FY | 65.35 Million CNY | 9.32% |
| 2020 Q4 | 19.79 Million CNY | 7.67% |
| 2019 FY | 59.78 Million CNY | 25.98% |
| 2019 Q3 | 16.03 Million CNY | 217.87% |
| 2019 Q2 | -13.59 Million CNY | -18.48% |
| 2019 Q1 | -11.47 Million CNY | 0.0% |
| 2019 Q4 | 18.67 Million CNY | 16.52% |
| 2018 FY | 47.45 Million CNY | 13.11% |
| 2017 FY | 41.95 Million CNY | 0.0% |